Overview

Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder

Status:
Withdrawn
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
The investigators will assess Li-induced gray matter volume changes with regard to the endophenotype of GSK3beta polymorphism. The changes of gray matter are supposed to be more attributable to neurotrophic and neuroprotective characteristics of Li, which were closely related to the inhibition of apoptotic activity of GSK3beta.
Phase:
Phase 4
Details
Lead Sponsor:
Ewha Womans University
Seoul National University Hospital
Collaborator:
Soon Chun Hyang University
Treatments:
Lithium Carbonate